title: Jekyll or Hyde: does Matrigel provide a more or less physiological environment in mammary repopulating assays?
abstract: In vivo transplantation is the current 'gold-standard' assay for evaluating mammary stem cell (MaSC) function. Matrigel, a reconstituted extracellular matrix derived from a mouse sarcoma line, is increasingly being utilized for mammary repopulating assays, although original studies were carried out in its absence. This matrix has also been shown to enhance tumor-initiating capacity. Whilst Matrigel increases the rate of engraftment by MaSCs, it also appears to promote progenitor activity that is distinct from bona fide stem cell activity. This caveat should be considered when interpreting mammary reconstitution assays that incorporate Matrigel, particularly when transplanting high cell numbers.
authors.forename: François
authors.initials: F
authors.lastname: Vaillant
authors.forename: Geoffrey J
authors.initials: GJ
authors.lastname: Lindeman
authors.forename: Jane E
authors.initials: JE
authors.lastname: Visvader
mesh_terms: D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects*; D003094:Collagen; D004338:Drug Combinations; D005109:Extracellular Matrix; D007797:Laminin; D008321:Mammary Glands, Animal / Q000166:cytology*; D051379:Mice; D011509:Proteoglycans; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000502:physiology*
chemical_list: D004338:Drug Combinations; D007797:Laminin; D011509:Proteoglycans; C059485:matrigel; D003094:Collagen